Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05183984
Title Niraparib With beVAcizumab After Complete cytoreductioN in Patients With ovArian Cancer (NIRVANA-1)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors ARCAGY/ GINECO GROUP
Indications

fallopian tube cancer

peritoneum cancer

ovary epithelial cancer

endometrioid ovary carcinoma

ovarian serous carcinoma

peritoneal serous adenocarcinoma

Therapies

Carboplatin + Niraparib + Paclitaxel

Bevacizumab + Carboplatin + Paclitaxel

Bevacizumab + Niraparib

Age Groups: adult | senior
Covered Countries FRA


No variant requirements are available.